A prospective randomized trial comparing clomiphene citrate with tamoxifencitrate for ovulation induction

Citation
R. Boostanfar et al., A prospective randomized trial comparing clomiphene citrate with tamoxifencitrate for ovulation induction, FERT STERIL, 75(5), 2001, pp. 1024-1026
Citations number
7
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
FERTILITY AND STERILITY
ISSN journal
00150282 → ACNP
Volume
75
Issue
5
Year of publication
2001
Pages
1024 - 1026
Database
ISI
SICI code
0015-0282(200105)75:5<1024:APRTCC>2.0.ZU;2-M
Abstract
Objective: To compare the rates of ovulation and pregnancy after tamoxifen citrate (TMX) or clomiphene citrate (CC) among anovulatory women with infer tility. Design: Prospective randomized trial. Setting: Infertility clinic in a university teaching hospital. Patient(s): Eighty-six anovulatory women under 40 years of age undergoing o vulation induction. Intervention(s): The women were assigned randomly to receive either TMX or CC on cycle days 5-9. Main Outcome Measure(s): Rates of ovulation and pregnancy for the two treat ment modalities. Result(s): The overall rate of ovulation in the TMX group was 50 of 113 (44 .2%) and in the CC group, 41 of 91 (45.1%). There were 10 pregnancies in th e TMX group and 6 pregnancies in the CC group. The cycle fecundity per ovul atory cycle was 20.0% in the TMX group and 14.6% in the CC group. Conclusion(s): The overall rate of ovulation and pregnancy were similar wit h TMX and CC. TMX is a suitable alternative agent to CC in the management o f anovulatory infertility. (Fertil Steril(R) 2001;75:1024-6. (C) 2001 by Am erican Society for Reproductive Medicine.).